T12	Exp 110 112	We
T13	Exp 134 138	that
T14	Exp 139 166	the drug undecylprodigiosin
T15	Exp 220 222	We
T16	Exp 305 310	which
T17	Exp 245 258	the mechanism
T18	Exp 368 370	We
T19	Exp 388 392	that
T20	Exp 393 414	the biological effect
T21	Exp 666 668	we
T22	Exp 674 678	that
T23	Exp 718 731	the induction
T24	Exp 830 832	We
T25	Exp 878 882	that
T26	Exp 929 931	We
T27	Exp 937 941	that
T28	Exp 1004 1018	the other hand
T29	Exp 1051 1065	the activation
T30	Exp 1069 1083	the NF-kappa B
T31	Exp 1172 1186	the inhibition
T32	Exp 1190 1205	the degradation
T33	Exp 1304 1306	it
T34	Exp 1374 1378	that
T35	Exp 1427 1429	We
T36	Exp 1439 1443	that
T37	Exp 1518 1522	that
T38	Exp 1444 1466	the prodigiosin family
R4	Coref Anaphora:T16 Antecedent:T39
R5	Coref Anaphora:T25 Antecedent:T40
R6	Coref Anaphora:T37 Antecedent:T41
T1	Protein 44 48	IL-2
T2	Protein 742 746	IL-2
T3	Protein 793 797	IL-2
T4	Protein 912 916	IL-2
T5	Protein 969 974	c-myc
T6	Protein 979 984	bcl-2
T7	Protein 1209 1224	I kappa B-alpha
T8	Protein 1229 1243	I kappa B-beta
T9	Protein 1390 1394	CD40
T39	Exp 294 303	PNU156804
T40	Exp 851 877	several molecular pathways
T41	Exp 1508 1517	molecules
